, Volume 15, Issue 3, pp 196-203
Date: 17 Jan 2004

Should age influence the choice of quantitative bone assessment technique in elderly women? The EPIDOS study

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

In a prospective cohort of 7,598 women aged 75 and over, we analyzed the effect of age on the ability of femoral neck bone mineral density (BMD) and of ultrasound (BUA and SOS) of the calcaneus to predict hip fracture. Unadjusted regression analysis showed that the risk of hip fracture was increased 1.7 times for one standard deviation increase in age (3.7 years). Overall, for a decrease of one standard deviation in quantitative bone measures, the risk was significantly increased by 2.2 times for BMD (1.9–2.5), 1.8 for BUA (1.6–2.1), and 1.9 for SOS (1.6–2.2). However the average relative risk associated with a decrease in BMD tends to diminish with advancing age, meaning that a smaller part of the risk is explained by BMD in the very elderly. This is confirmed by the areas under the ROC curves (AUC) of BMD that are significantly better before 80 years (0.75 [0.73–0.76]) than after (0.65 [0.63–0.67] in group 80–84 years and 0.65 [0.61–0.68] in group ≥85). On the other hand, as the absolute risk increases exponentially with age, the number of hip fractures attributable to a low BMD is still important in the very elderly, the risk difference between the lowest and the highest quartile of BMD is 25 hip fractures / 1,000 woman-years in the group ≥85 compared with 16 in the two other groups. Thus, after 80, quantitative assessment of bone may still be of interest for clinical decisions. Compared with quantitative ultrasound parameters, the ability of BMD to predict hip fracture was significantly superior to that of BUA and SOS only before the age of 80 (AUC of BMD 0.75 [0.73–0.76], BUA 0.67 [0.66–0.69], SOS 0.67 [0.65–0.69]). For patients older than 80, we did not observe significant differences in AUC between DXA and QUS to predict hip fracture.

The named authors wrote this article on behalf of the EPIDOS Study Group. Coordinators: G. Bréart and P. Dargent-Molina (epidemiology), P.J. Meunier and A.M. Schott (clinical aspects), D. Hans (DXA and ultrasound quality control), P.D. Delmas (biochemistry). Principal investigators: J.L. Sebert and C. Baudoin (Amiens), A.M. Schott and M.C. Chapuy (Lyon), C. Marcelli and F. Favier (Montpellier), C.J. Menkès, C. Cormier, and E. Hausherr (Paris), and H. Grandjean and C. Ribot (Toulouse).